Towards Healthcare

News

Your Daily Gateway to Essential News in Healthcare, Science, Technology and Business Worldwide

Myllia’s Echoes of Silenced Genes: positive noise in CRISPR perturbation
28 January 2026

Myllia’s Echoes of Silenced Genes: positive noise in CRISPR perturbation

Introduction Myllia Biotechnology is a champion in merging bandwidth, CRISPR screening, and single-cell RNA sequencing. The company is popular as ‘Aelian Biotechnology’ along with its advanced genetic perturbation usage in specifically cancer and human cells. The company’s sequenc...

Lexicon’s ‘Get set go’ attitude after entering Phase 3
28 January 2026

Lexicon’s ‘Get set go’ attitude after entering Phase 3

Introduction Lexicon Pharmaceuticals entered the competition in 1995 with its excellent small molecule drugs harnessed with gene knockout technology. The main target of the company is chronic issues in oncology, neurology and cardiometabolism. Its popular products like LX9211 and INPEFA are a boon ...

BMS, along with Janux, is ready to upgrade cancer drugs
28 January 2026

BMS, along with Janux, is ready to upgrade cancer drugs

Introduction Bristol Myers Squibb (BMS), a leading biopharmaceutical company, aims to address immunology, cardiovascular, haematology, and oncology with its innovative and effective medicines, backed by a smart approach to discovering, establishing, and delivering excellence in these complex condit...

IntraBio, baby steps for the treatment of Ataxia-Telangiectasia
27 January 2026

IntraBio, baby steps for the treatment of Ataxia-Telangiectasia

Introduction IntraBio Inc. operates in the healthy air of Austin, Texas, with its innovative treatment development for common and rare neurodegenerative conditions. The company sharpens its smartness from Munich and the University of Oxford with its delivery of essential products to the calcium bui...

Charles River and Gazi University to offer plasmid DNA together
27 January 2026

Charles River and Gazi University to offer plasmid DNA together

Introduction Charles River Laboratories International, Inc., a well-known Contract Research Organisation (CRO), delivers fundamental services and products for government customers, academic space, biotech and pharmaceuticals to support and bolster development, manufacturing and drug discovery. The ...

Roche’s Investment to redeem the obesity treatments
27 January 2026

Roche’s Investment to redeem the obesity treatments

Introduction Roche (F. Hoffmann-La Roche) is a multinational healthcare company that is a champion in merging diagnostics and pharmaceuticals to innovate treatments in immunology, infectious diseases, CNS and oncology. The company’s personalised healthcare brings value and growth to the treat...

J&J’s eyes are on $100 billion
27 January 2026

J&J’s eyes are on $100 billion

Introduction Johnson & Johnson is a well-known company, recognised for its MedTech innovations and effective, innovative pharmaceuticals. Since 1886, the company has contributed to and advanced the journey in the vast healthcare sector with greater confidence and dedication, poised to thrive in...

 Supreme Court to Weigh Whether Federal Law Blocks Roundup Cancer Lawsuits
23 January 2026

Supreme Court to Weigh Whether Federal Law Blocks Roundup Cancer Lawsuits

The U.S. Supreme Court said it will take up a closely watched case that could determine whether tens of thousands of people who claim the weedkiller Roundup caused their cancer will be allowed to pursue their lawsuits in court, or whether federal pesticide law will effectively shut those cases down....

Bayer Sues Pfizer, Moderna, BioNTech and J&J Over Alleged COVID-19 Vaccine Patent Infringement
23 January 2026

Bayer Sues Pfizer, Moderna, BioNTech and J&J Over Alleged COVID-19 Vaccine Patent Infringement

Bayer has launched a new round of high-stakes patent litigation against the makers of several leading COVID-19 vaccines, alleging that they improperly used intellectual property originally developed by Monsanto decades ago.  In separate lawsuits filed in U.S. federal courts, the German life sc...

Tanabe’s positive results bring life to EPP and XLP patients
23 January 2026

Tanabe’s positive results bring life to EPP and XLP patients

Introduction Tanabe Pharma America, Inc., formerly Mitsubishi Tanabe Pharma America, is a U.S. division of Japan’s Tanabe Pharma Corporation. The company is known for its marketing skills and introducing treatments for extreme areas of rare diseases, immune-inflammation and CNS. The company&r...

WhatsApp